acebutolol has been researched along with Cardiac Remodeling, Ventricular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dauw, J; Dupont, M; Herbots, L; Martens, P; Mullens, W; Somers, F; Timmermans, P; Verwerft, J | 1 |
| Gronda, E; Iacoviello, M; Palazzuoli, A | 1 |
| Bruckers, L; Dauw, J; Dendale, P; Dupont, M; Herbots, L; Martens, P; Mullens, W; Nijst, P; Tang, WHW; Vandervoort, P | 1 |
| Jankowska, EA; Leszek, P; Mackiewicz, U; Mączewski, M; Oknińska, M; Paterek, A; Ponikowski, P | 1 |
1 review(s) available for acebutolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Recent advances in pharmacological treatment of heart failure.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiotonic Agents; Drug Combinations; Ferric Compounds; Heart Failure; Heterocyclic Compounds, 2-Ring; Hospitalization; Humans; Iron Deficiencies; Maltose; Pyrimidines; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Urea; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2021 |
2 trial(s) available for acebutolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy.
Topics: Administration, Intravenous; Adult; Cardiac Resynchronization Therapy; Double-Blind Method; Female; Ferric Compounds; Heart Failure; Humans; Iron Deficiencies; Male; Maltose; Prospective Studies; Ventricular Remodeling | 2019 |
The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial.
Topics: Cardiac Resynchronization Therapy; Ferric Compounds; Heart Failure; Humans; Iron Deficiencies; Maltose; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2021 |
1 other study(ies) available for acebutolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Intravenous ferric carboxymaltose does not provide benefits in reperfused acute myocardial infarction in the rat with normal iron status.
Topics: Administration, Intravenous; Animals; Arrhythmias, Cardiac; Echocardiography; Ferric Compounds; Hemodynamics; Hypertrophy, Left Ventricular; Iron; Male; Maltose; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar; Ventricular Remodeling | 2021 |